Glycaemia and heart failure in diabetes types 1 and 2

The Lancet

Volumn 378, Issue 9786, 2011, Pages 103-104

  Opie, Lionel H ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; HEMOGLOBIN A1C; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

AGE; ANGINA PECTORIS; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY RECANALIZATION; DEATH; DIABETIC CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCEMIC CONTROL; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HEART TRANSPLANTATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INTRAABDOMINAL FAT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; STROKE;

EID: 79960242550     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60787-3     Document Type: Note

References (15)

1. M Lind, I Bounias, M Olsson, S Gudbjörnsdottir, A-M Svensson, A Rosengren Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study Lancet 2011 10.1016/S0140-6736(11) 60471-6 published online June 25.
2. DM Nathan, PA Cleary, JY Backlund for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653 (Pubitemid 41817713)
3. P Herrero, LR Peterson, JB McGill et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus J Am Coll Cardiol 47 2006 598 604 (Pubitemid 43170851)
4. S Boudina, ED Abel Diabetic cardiomyopathy revisited Circulation 115 2007 3213 3223 (Pubitemid 47012236)
5. F Giacco, M Brownlee Oxidative stress and diabetic complications Circ Res 107 2010 1058 1070
6. S Carugo, C Giannattasio, I Calchera et al. Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus J Hypertens 19 2001 1675 1680 (Pubitemid 32783787)
7. S Sharma, JV Adrogue, L Golfman et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart FASEB J 18 2004 1692 1700 (Pubitemid 39463708)
8. JM McGavock, I Lingvay, I Zib et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study Circulation 116 2007 1170 1175 (Pubitemid 47360218)
9. LJ Rijzewijk, RW van der Meer, JW Smit et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus J Am Coll Cardiol 52 2008 1793 1799
10. R Katare, A Caporali, L Zentilin et al. Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling Circ Res 108 2011 1238 1251
11. P Gaede, H Lund-Andersen, HH Parving, O Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591 (Pubitemid 351214285)
12. N Yakubovich, HC Gerstein Serious cardiovascular outcomes in diabetes: the role of hypoglycemia Circulation 123 2011 342 348
13. JL Gross, CK Kramer, CB Leitão for the Diabetes and Endocrinology Meta-analysis Group (DEMA) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis Ann Intern 154 2011 672 679
14. LH Opie, DM Yellon, BJ Gersh Controversies in the cardiovascular management of type 2 diabetes Heart 97 2011 6 14
15. JS Yudkin, B Richter, EAM Gale Intensified glucose control in type 2 diabetes - whose agenda? Lancet 377 2011 1220 1222